Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics (original) (raw)
AI-generated Abstract
Magnetoliposomes (MLs) represent a cutting-edge development in the field of nanomedicine, serving as multimodal contrast agents for advanced molecular imaging and cancer nanotheragnostics. These innovative agents utilize superparamagnetic nanocrystals, supported by phospholipid coatings to enhance biocompatibility and stability, thereby addressing the limitations of traditional imaging probes. The research underscores the potential of MLs to facilitate early disease detection and improve therapeutic outcomes through their versatile applications in imaging and targeted treatment strategies.
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.